Published in Pharma Law Weekly, January 10th, 2006
According to a study from the United States, "This study examined the impact of body mass index (BMI) category on cardiovascular risk factors such as systolic blood pressure (SBP), high-density lipoprotein (HDL) and total cholesterol (TC). Voluntary coronary heart disease (CHD) risk screenings were conducted in 18 states. A mobile screening unit and team were used to collect data."
A.V. Joshi and colleagues at Novo Nordisk explained, "Respondents were classified as per World Health Organization (WHO) guidelines...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.